Navigation Links
amfAR Appoints Dr. Annette Sohn as Vice President of Global Initiatives
Date:5/28/2008

Renowned pediatrician will lead AIDS research foundation's international program, including its TREAT Asia initiative

NEW YORK, May 28 /PRNewswire-USNewswire/ -- amfAR, The Foundation for AIDS Research, has appointed Annette Sohn, MD, as vice president for global initiatives and director of TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia), announced Kevin Robert Frost, amfAR's chief executive officer. Dr. Sohn will take up her appointment on September 1, 2008.

Dr. Sohn is a highly regarded pediatrician and researcher with extensive experience treating HIV/AIDS among women and children in Southeast Asia. She is an assistant professor in the Division of Pediatric Infectious Diseases at the University of California, San Francisco (UCSF), and former Vietnam country representative for the UCSF Institute for Global Health.

Dr. Sohn is based in Ho Chi Minh City, where she has directed a pediatric HIV research program in collaboration with Children's Hospital #1 and the Ho Chi Minh City AIDS Committee. Her projects there included studies of diagnostic testing and monitoring in HIV-exposed infants, stigma and discrimination in the context of prevention of mother-to-child transmission, and contraception and reproductive health outcomes of HIV-positive women.

She is a former member of amfAR's TREAT Asia steering committee, pediatric network, and the Pediatric HIV Observational Database working group. Dr. Sohn also is a technical advisor to PEPFAR-Vietnam, assisting in-country programs on coordination, protocols, and capacity building for scaling up their comprehensive pediatric antiretroviral treatment programs.

"I am delighted that Annette Sohn will join amfAR in a leadership capacity," Frost said. "Dr. Sohn brings a unique combination of practical medical experience, cultural understanding, groundbreaking research, and a dedication to amfAR's global efforts to defeat the HIV/AIDS epidemic."

Recently, amfAR has expanded its global efforts to eradicate HIV/AIDS. In addition to TREAT Asia, which has its main office in Bangkok, amfAR's MSM Initiative is working to reduce rates of HIV infection and transmission among men who have sex with men in resource-limited countries. Dr. Sohn will also oversee the MSM Initiative.

In her role with amfAR, Dr. Sohn will be based in amfAR's Bangkok, Thailand, office and will lead a staff of 20.

"I welcome the opportunity to work full-time on amfAR's global initiatives," Dr. Sohn said. "The battle against HIV/AIDS demands the commitment of all sectors of society and must be grounded in evidence-based research, policy and practice. amfAR has a well-deserved reputation as a leader in the fight against this global epidemic and addressing the suffering it brings to vulnerable populations."

"Asia has become one of the world's epicenters of the AIDS epidemic, and as such is an extremely important front in the war against AIDS," said Dr. Adeeba Kamarulzaman, head of the Infectious Diseases Unit at the University of Malaya Medical Centre and chair of the TREAT Asia steering committee. "Although there is still no cure for AIDS, recent scientific advances have provided exciting opportunities for refining AIDS treatments. Dr. Sohn's background, accomplishments, and experience in Asia make her the ideal candidate to lead amfAR's Global Initiatives and the TREAT Asia program."

About amfAR

amfAR, The Foundation for AIDS Research, is one of the world's leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of sound AIDS-related public policy. Since 1985, amfAR has invested nearly $275 million in its programs and has awarded grants to more than 2,000 research teams worldwide. For more information about amfAR, visit http://www.amfar.org.


'/>"/>
SOURCE American Foundation for AIDS Research (amFAR)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. amfARs MSM Initiative Seeks Proposals From Front-Line Groups Working on HIV in Developing Countries
2. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
3. amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
4. WorldHeart Appoints David Pellone Chief Financial Officer
5. Novo Nordisk Appoints New Leader of North American Business
6. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
7. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
8. Resonant Medical Appoints New Vice President of Global Sales
9. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of ... a lot to offer to the discussion of dealing with excess skin oil. “Oily skin ... many home remedies that can help remove the oily shine while keeping the skin fresh ...
(Date:3/28/2017)... ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that reveals the ... , “There were things that his parents and teachers had asked of him that he ... he was going to defy the Almighty Creator. There were some who would have felt ...
(Date:3/27/2017)... FL (PRWEB) , ... March 27, 2017 , ... ... new patients for clear braces. People who want straight teeth without the extensive ... Invisalign® in Clearwater, FL, without acquiring a referral. A custom-designed series of ...
(Date:3/27/2017)... ... 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and ... key role this treatment plays in protecting oral health, along with the benefits of ... who need a root canal in White Plains, NY or their second location in ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... A study ... Buckingham MD, and his colleague, Sudeep Roy, MD, was recently published in the ... Electrocautery Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the use of ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  Sanderling Ventures, portfolio company, Torax Medical, ... of Johnson & Johnson. Torax manufactures and markets the ... gastro-esophageal reflux disease (GERD). The LINK device is ... the procedure is currently available in the U.S. ... was founded by Sanderling Ventures, Mayo Medical Ventures ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
Breaking Medicine Technology: